DCTH
Delcath Systems Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Best Medical Devices Stocks 2026 →
Delcath Systems (DCTH) Stock: Buy, Sell, or Hold?
$19.91
-0.64 (-3.14%)
▼
5d:
-1.8%
30d:
+41.37%
90d:
+18.06%
Open in Live Scanner
70/30 Portfolio Builder
Last Earnings: Nov 09, 2026
Updated Nov 13, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (14%)
Quality Score
36/100
Position
EXTENDED
30-Day Fair Range
$13.48 – $17.85
Position: EXTENDED
Forward P/E & Valuation
75.4x
CHEAP
vs 197.4x historical avg
Wall Street Target
$28.60
+39.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$14.20 / $22.51
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: DCTH is 11.5% above its trading range ($17.85). Market expects -27.4% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Get Alerted When DCTH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$13.27
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$8.24
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DCTH is currently trading at $19.91, which is considered extended relative to its 30-day fair value range of $13.48 to $17.85. From a valuation perspective, the stock is trading at a discount (Forward PE: 75.4) compared to its historical average (197.4). Remarkably, the market is currently pricing in an annual earnings decline of 27.4% over the next few years. This pessimistic expectation contrasts with the company's recent 750.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, DCTH is in a uptrend. Immediate support is located at $14.20, while resistance sits at $22.51. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: DCTH scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $28.60 (+39.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DCTH is in a uptrend. Immediate support is located at $14.20, while resistance sits at $22.51. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: DCTH scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $28.60 (+39.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$13.48 -
$17.85
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
14.3%
Trading Range & Key Levels
30-Day Trading Range
$13.48 -
$17.85
Current vs Trading Range
EXTENDED
Support Level
$14.20
Resistance Level
$22.51
Current Trend
Uptrend
Technical data as of
Nov 16, 2026
Institutional Signals, 13F Whale Activity & Setup Structure
Quantitative Research Feed
Phase & Gamma Walls
BREAKOUT
Days in Phase:
66d (53% conf)
Put Wall / Support:
$18 (59 OI)
Call Wall / Resist:
$23 (524 OI)
Technical Setup Structure
MONITORING
Absorption:
Inactive (CMF 0.14)
Pullback / Drawdown:
-5.6% from 52W High
Consolidation:
Trending (ADX 34.3)
Quantitative Signal Breakdown
- BEARISH: Price significantly overextended (+11.5% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.1%)
- BULLISH: Trading 39.2% below Wall St target ($28.60)
- WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
75.41
Wall Street Target
$28.60
(+39.2%)
Revenue Growth (YoY)
70.7%
Earnings Growth (YoY)
750.0%
Profit Margin
6.0%
Valuation Discount vs History
-27.4% cheaper
PE vs Historical
75.4 vs 197.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-27.4%
(market-implied from PE analysis)
1-Year Target
$18.50
(-10%)
2-Year Target
$16.65
(-19%)
3-Year Target
$14.98
(-27%)
3-Yr Target (if PE normalizes)
(PE: 75→197)
$39.21
(+91%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 75.4, Growth: 36.3%)
$51.98
(+153%)
Base:
(SPY PE: 19.9, Growth: 36.3%)
$13.69
(-33%)
Bear:
(PE: 16.9, Growth: 36.3%)
$11.64
(-43%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 75.4 to 197.4
Stabilization Target:
$53.79
(+161.8%)
PE Expansion Potential:
+161.8%
Share DCTH Analysis
Share this live DCTH analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (DCTH)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 16, 2026
Daily AI digest
AI Retail Discussion Summary:
Bullish sentiment on StockTwits regarding $DCTH's expansion into hospital systems with multiple locations, as opposed to academic centers.
Key Retail Themes:
Expansion into hospital systems
Many locations and procedures
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 16, 2026 1:47 PM ET
Data refreshes hourly during market hours. Next update: 2:47 PM
Data refreshes hourly during market hours. Next update: 2:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DCTH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$99 | 54 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 48 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
30 analysts |
$339 | 44 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$113 | 32 SELL |
|
GEHC
GE HealthCare Technologi… |
BUY
22 analysts |
$88 | 33 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive DCTH Research Pages
DCTH Technical Chart
DCTH Price Prediction
DCTH Intrinsic Value DCF
DCTH Earnings Date
Why is DCTH Moving Today?
DCTH Investment Advisor
DCTH Fair Price Analyzer
DCTH Target Price Playground
DCTH LEAP Simulator
DCTH Supply Chain Tear-Down
Engineering R&D & Supply-Chain Velocity Hub
AI Chip Cost & Reticle Wall Visualizer
House Thesis Scoreboard & Risk Guard
DCTH Competitors
Part B: Tradestie Flagship Market Scanners